Lyra Therapeutics (LYRA)
(Delayed Data from NSDQ)
$0.39 USD
0.00 (-0.85%)
Updated May 9, 2024 04:00 PM ET
After-Market: $0.39 0.00 (0.91%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.34 |
EPS Last Quarter | -0.35 |
Last EPS Surprise | -34.62% |
ABR | 2.83 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.18 |
Next Year | -0.81 |
EPS (TTM) | -1.17 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.43M | 0.43M | 1.40M | 1.27M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 0.53M | 0.53M | 2.13M | 1.59M |
Low Estimate | 0.32M | 0.32M | 0.50M | 0.94M |
Year ago Sales | 0.46M | 0.54M | 1.56M | 1.40M |
Year over Year Growth Est. | -7.61% | -21.30% | -10.14% | -9.64% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.34 | -0.31 | -1.18 | -0.81 |
# of Estimates | 4 | 3 | 5 | 4 |
Most Recent Consensus | -0.34 | -0.32 | -1.30 | -1.23 |
High Estimate | -0.31 | -0.28 | -0.91 | -0.28 |
Low Estimate | -0.36 | -0.33 | -1.33 | -1.23 |
Year ago EPS | -0.33 | -0.27 | -1.23 | -1.18 |
Year over Year Growth Est. | -3.03% | -14.81% | 4.07% | 31.31% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 2 | 2 |
Up Last 30 Days | 0 | 0 | 0 | 3 |
Up Last 60 Days | 0 | 0 | 1 | 2 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 3 | 3 | 1 |
Down Last 60 Days | 2 | 2 | 4 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.34 | -0.31 | -1.18 | -0.81 |
7 Days Ago | -0.33 | -0.31 | -1.28 | -1.23 |
30 Days Ago | -0.25 | -0.25 | -1.04 | -1.17 |
60 Days Ago | -0.26 | -0.23 | -1.07 | -1.23 |
90 Days Ago | -0.26 | -0.24 | -1.08 | -1.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.34 | -0.31 | -1.18 | -0.81 |
Zacks Consensus Estimate | -0.34 | -0.31 | -1.18 | -0.81 |
Earnings ESP | 0.00% | 0.00% | 0.59% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.35 | -0.22 | -0.27 | -0.33 | NA |
Estimate | -0.26 | -0.33 | -0.33 | -0.44 | NA |
Difference | -0.09 | 0.11 | 0.06 | 0.11 | 0.05 |
Surprise | -34.62% | 33.33% | 18.18% | 25.00% | 10.47% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more